Item 8.01 OTHER EVENTS.
On January 25, 2022, Oragenics, Inc. (the "Company") called to order its
reconvened Annual Meeting of Shareholders (the "Annual Meeting"). At the Annual
Meeting, there were not present or represented by proxy a sufficient number of
shares of the Company's common stock in order to a constitute quorum. The
Company again adjourned the Annual Meeting until February 25, 2022 at 4:00 p.m.
Eastern Time. At that time, the Annual Meeting will be reconvened at the offices
of Shumaker, Loop, & Kendrick, Bank of America Plaza, 101 E Kennedy Blvd., Suite
2800, Tampa, FL 33602.
The record date for the Annual Meeting remains October 1, 2021. Shareholders of
the Company who have previously submitted their proxy or otherwise voted and who
do not want to change their vote do not need to take any action.
No changes have been made in the proposals to be voted on by shareholders at the
Annual Meeting. The Company strongly encourages all of its shareholders to read
the Company's definitive proxy statement on Schedule 14A, filed with
the Securities and Exchange Commission (the "SEC") on October 13, 2021 (the
"Proxy Statement") and other proxy materials relating to the Annual Meeting,
which are available free of charge on the SEC's website at www.sec.gov.
On January 26, 2022, the Company issued a press release to announce the
adjournment, which is furnished as Exhibit 99.1 to this Current Report on Form
8-K. The information in the press release furnished as Exhibit 99.1 hereto shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, or incorporated by reference into any of the
Company's filings under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in any such
filing.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release dated January 26, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses
ORAGENICS, INC. 
